Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. KRIS MG; ROILA F; DEMULDER PHM; MARTY M
   DELAYED EMESIS FOLLOWING ANTICANCER CHEMOTHERAPY
   Supportive care in cancer
   
   M.G. Kris et al., "DELAYED EMESIS FOLLOWING ANTICANCER CHEMOTHERAPY", Supportive care in cancer, 6(3), 1998, pp. 228-232
2. DEMULDER PHM; ROILA F; KRIS MG; MARTY MM
   CONSENSUS REGARDING MULTIPLE DAY AND RESCUE ANTIEMETIC THERAPY
   Supportive care in cancer
   
   P.H.M. Demulder et al., "CONSENSUS REGARDING MULTIPLE DAY AND RESCUE ANTIEMETIC THERAPY", Supportive care in cancer, 6(3), 1998, pp. 248-252
3. ROILA F; DELFAVERO A; GRALLA RJ; TONATO M; AAPRO MS; ANDREWS PLR; BALLATORI E; DEMULDER PHM; DICATO MA; DUBOIS A; FEYER PC; GANDARA DR; GRALLA RJ; GRALLA RJ; GROSHEN S; GRUNBERG SM; HERRSTEDT J; HESKETH PJ; JOSS RA; KRIS MG; MARTY MM; MORROW GR; NAYLOR RJ; OLVER IN; SMYTH JF; SPITZER TR; STEWART A
   PREVENTION OF CHEMOTHERAPY-INDUCED AND RADIOTHERAPY-INDUCED EMESIS - RESULTS OF THE PERUGIA CONSENSUS CONFERENCE
   Annals of oncology
   
   F. Roila et al., "PREVENTION OF CHEMOTHERAPY-INDUCED AND RADIOTHERAPY-INDUCED EMESIS - RESULTS OF THE PERUGIA CONSENSUS CONFERENCE", Annals of oncology, 9(8), 1998, pp. 811-819
4. TJANHEIJNEN VCG; VLASVELD LT; DEMULDER PHM
   SEMINOMA AND SARCOIDOSIS - A CAUSE FOR FALSE-POSITIVE MEDIASTINAL UPTAKE IN PET - RESPONSE
   Annals of oncology
   
   V.C.G. Tjanheijnen et al., "SEMINOMA AND SARCOIDOSIS - A CAUSE FOR FALSE-POSITIVE MEDIASTINAL UPTAKE IN PET - RESPONSE", Annals of oncology, 9(8), 1998, pp. 924-924
5. TJANHEIJNEN VCG; VLASVELD LT; PERNET EPPM; PAUWELS P; DEMULDER PHM
   COINCIDENCE OF SEMINOMA AND SARCOIDOSIS - A MYTH OR FACT
   Annals of oncology
   
   V.C.G. Tjanheijnen et al., "COINCIDENCE OF SEMINOMA AND SARCOIDOSIS - A MYTH OR FACT", Annals of oncology, 9(3), 1998, pp. 321-325
6. LOUWERENS M; SCHORNAGEL J; DEMULDER PHM; DEWIT R
   A DOSE-FINDING STUDY OF PACLITAXEL (TAXOL) ADDED TO FIXED DOSES OF BLEOMYCIN, ETOPOSIDE, CISPLATIN (BEP) IN PATIENTS WITH ADVERSE PROGNOSISGERM-CELL CANCER OR CARCINOMA OF UNKNOWN PRIMARY (CUP)
   Annals of oncology
   
   M. Louwerens et al., "A DOSE-FINDING STUDY OF PACLITAXEL (TAXOL) ADDED TO FIXED DOSES OF BLEOMYCIN, ETOPOSIDE, CISPLATIN (BEP) IN PATIENTS WITH ADVERSE PROGNOSISGERM-CELL CANCER OR CARCINOMA OF UNKNOWN PRIMARY (CUP)", Annals of oncology, 9, 1998, pp. 366-366
7. FOSSA SD; KAYE SB; MEAD GM; CULLEN M; DEWIT R; BODROGI I; VANGROENINGEN CJ; DEMULDER PHM; STENNING S; LALLEMAND E; DEPRIJCK L; COLLETTE L
   FILGRASTIM DURING COMBINATION CHEMOTHERAPY OF PATIENTS WITH POOR-PROGNOSIS METASTATIC GERM-CELL MALIGNANCY
   Journal of clinical oncology
   
   S.D. Fossa et al., "FILGRASTIM DURING COMBINATION CHEMOTHERAPY OF PATIENTS WITH POOR-PROGNOSIS METASTATIC GERM-CELL MALIGNANCY", Journal of clinical oncology, 16(2), 1998, pp. 716-724
8. STEFFENS MG; BOERMAN OC; OOSTERWIJK E; OYEN WJG; DEMULDER PHM; WITJES JA; OOSTERHOF GON; DEBRUYNE FMJ; CORSTENS FHM
   PHASE I II RADIOIMMUNOTHERAPY WITH I-131-LABELED CHIMERIC MONOCLONAL-ANTIBODY CG250 IN PATIENTS WITH METASTASIZED RENAL-CELL CARCINOMA/
   The Journal of nuclear medicine
   
   M.G. Steffens et al., "PHASE I II RADIOIMMUNOTHERAPY WITH I-131-LABELED CHIMERIC MONOCLONAL-ANTIBODY CG250 IN PATIENTS WITH METASTASIZED RENAL-CELL CARCINOMA/", The Journal of nuclear medicine, 39(5), 1998, pp. 1089-1089
9. STEFFENS MG; BOERMAN OC; OYEN WJG; DEMULDER PHM; WITJES JA; OOSTERHOF GON; CORSTENS FHM; DEBRUYNE FMJ; OOSTERWIJK E
   RADIOIMMUNOTHERAPY WITH I-131 CG250 MONOCLONAL-ANTIBODY IN PATIENTS WITH METASTASIZED RCC, A PHASE I II STUDY/
   The Journal of urology
   
   M.G. Steffens et al., "RADIOIMMUNOTHERAPY WITH I-131 CG250 MONOCLONAL-ANTIBODY IN PATIENTS WITH METASTASIZED RCC, A PHASE I II STUDY/", The Journal of urology, 159(5), 1998, pp. 562-562
10. DEWIT R; COLLETTE L; SYLVESTER R; DEMULDER PHM; SLEIJFER DT; HUININK WWT; KAYE SB; VANOOSTEROM AT; BOVEN E; STOTER G
    SERUM ALPHA-FETOPROTEIN SURGE AFTER THE INITIATION OF CHEMOTHERAPY FOR NONSEMINOMATOUS TESTICULAR CANCER HAS AN ADVERSE PROGNOSTIC-SIGNIFICANCE
    British Journal of Cancer
    
    R. Dewit et al., "SERUM ALPHA-FETOPROTEIN SURGE AFTER THE INITIATION OF CHEMOTHERAPY FOR NONSEMINOMATOUS TESTICULAR CANCER HAS AN ADVERSE PROGNOSTIC-SIGNIFICANCE", British Journal of Cancer, 78(10), 1998, pp. 1350-1355
11. DEWIT R; PAWINSKY A; STOTER G; VANOOSTEROM AT; FOSSA SD; PARIDAENS R; SVEDBERG A; DEMULDER PHM
    EORTC PHASE-II STUDY OF DAILY ORAL LINOMIDE IN METASTATIC RENAL-CELL CARCINOMA PATIENTS WITH GOOD PROGNOSTIC FACTORS
    European journal of cancer
    
    R. Dewit et al., "EORTC PHASE-II STUDY OF DAILY ORAL LINOMIDE IN METASTATIC RENAL-CELL CARCINOMA PATIENTS WITH GOOD PROGNOSTIC FACTORS", European journal of cancer, 33(3), 1997, pp. 493-495
12. PAWINSKI A; VANOOSTEROM AT; DEWIT R; FOSSA S; CROLES J; SVEDBERG A; LENTZ MA; DEMULDER PHM
    AN EORTC PHASE-II STUDY OF THE EFFICACY AND SAFETY OF LINOMIDE IN THETREATMENT OF ADVANCED RENAL-CELL CARCINOMA
    European journal of cancer
    
    A. Pawinski et al., "AN EORTC PHASE-II STUDY OF THE EFFICACY AND SAFETY OF LINOMIDE IN THETREATMENT OF ADVANCED RENAL-CELL CARCINOMA", European journal of cancer, 33(3), 1997, pp. 496-499
13. PLANTING AST; DEMULDER PHM; DEGRAEFF A; VERWEIJ J
    PHASE-II STUDY OF WEEKLY HIGH-DOSE CISPLATIN FOR 6 CYCLES IN PATIENTSWITH LOCALLY ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    European journal of cancer
    
    A.S.T. Planting et al., "PHASE-II STUDY OF WEEKLY HIGH-DOSE CISPLATIN FOR 6 CYCLES IN PATIENTSWITH LOCALLY ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK", European journal of cancer, 33(1), 1997, pp. 61-65
14. TJANHEIJNEN VCG; OOSTERHOF GON; DEWIT R; DEMULDER PHM
    TREATMENT IN GERM-CELL TUMORS - STATE-OF-THE-ART
    European journal of surgical oncology
    
    V.C.G. Tjanheijnen et al., "TREATMENT IN GERM-CELL TUMORS - STATE-OF-THE-ART", European journal of surgical oncology, 23(2), 1997, pp. 110-117
15. HORWICH A; SLEIJFER DT; FOSSA SD; KAYE SB; OLIVER RTD; CULLEN MH; MEAD GM; DEWIT R; DEMULDER PHM; DEARNALEY DP; COOK PA; SYLVESTER RJ; STENNING SP
    RANDOMIZED TRIAL OF BLEOMYCIN, ETOPOSIDE, AND CISPLATIN COMPARED WITHBLEOMYCIN, ETOPOSIDE, AND CARBOPLATIN IN GOOD-PROGNOSIS METASTATIC NONSEMINOMATOUS GERM-CELL CANCER - A MULTIINSTITUTIONAL MEDICAL-RESEARCH-COUNCIL -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER TRIAL
    Journal of clinical oncology
    
    A. Horwich et al., "RANDOMIZED TRIAL OF BLEOMYCIN, ETOPOSIDE, AND CISPLATIN COMPARED WITHBLEOMYCIN, ETOPOSIDE, AND CARBOPLATIN IN GOOD-PROGNOSIS METASTATIC NONSEMINOMATOUS GERM-CELL CANCER - A MULTIINSTITUTIONAL MEDICAL-RESEARCH-COUNCIL -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER TRIAL", Journal of clinical oncology, 15(5), 1997, pp. 1844-1852
16. MEAD GM; STENNING SP; COOK P; FOSSA SD; HORWICH A; KAYE SB; OLIVER RTD; DEMULDER PHM; DEWIT R; STOTER G; SYLVESTER RJ; BAJORIN DF; BOSL GJ; MAZUMDAR M; NICHOLS CR; AMATO R; PIZZOCARO G; DROZ JP; KRAMAR A; DAUGAARD G; CORTESFUNES H; PAZARES L; LEVI JA; COLLS BM; HARVEY VJ; COPPIN C
    INTERNATIONAL GERM-CELL CONSENSUS CLASSIFICATION - A PROGNOSTIC FACTOR-ERASED STAGING SYSTEM FOR METASTATIC GERM-CELL CANCERS
    Journal of clinical oncology
    
    G.M. Mead et al., "INTERNATIONAL GERM-CELL CONSENSUS CLASSIFICATION - A PROGNOSTIC FACTOR-ERASED STAGING SYSTEM FOR METASTATIC GERM-CELL CANCERS", Journal of clinical oncology, 15(2), 1997, pp. 594-603
17. PUNT CJA; VANHERPEN CML; JANSEN RLH; VREUGDENHIL G; MULLER EW; DEMULDER PHM
    CHEMOIMMUNOTHERAPY WITH BLEOMYCIN, VINCRISTINE, LOMUSTINE, DACARBAZINE (BOLD) PLUS INTERFERON-ALPHA FOR METASTATIC MELANOMA - A MULTICENTERPHASE-II STUDY
    British Journal of Cancer
    
    C.J.A. Punt et al., "CHEMOIMMUNOTHERAPY WITH BLEOMYCIN, VINCRISTINE, LOMUSTINE, DACARBAZINE (BOLD) PLUS INTERFERON-ALPHA FOR METASTATIC MELANOMA - A MULTICENTERPHASE-II STUDY", British Journal of Cancer, 76(2), 1997, pp. 266-269
18. PUNT CJA; VOEST EE; TUENI E; VANOOSTEROM AT; BACKX A; DEMULDER PHM; HECQUET B; LUCAS C; GERARD B; BLEIBERG H
    PHASE IB STUDY OF DOXORUBICIN IN COMBINATION WITH THE MULTIDRUG-RESISTANCE REVERSING AGENT S9788 IN ADVANCED COLORECTAL AND RENAL-CELL CANCER
    British Journal of Cancer
    
    C.J.A. Punt et al., "PHASE IB STUDY OF DOXORUBICIN IN COMBINATION WITH THE MULTIDRUG-RESISTANCE REVERSING AGENT S9788 IN ADVANCED COLORECTAL AND RENAL-CELL CANCER", British Journal of Cancer, 76(10), 1997, pp. 1376-1381
19. DEWIT R; SYLVESTER R; TSITSA C; DEMULDER PHM; SLEYFER DT; HUININK WWT; KAYE SB; VANOOSTEROM AT; BOVEN E; VERMEYLEN K; STOTER G
    TUMOR-MARKER CONCENTRATION AT THE START OF CHEMOTHERAPY IS A STRONGERPREDICTOR OF TREATMENT FAILURE THAN MARKER HALF-LIFE - A STUDY IN PATIENTS WITH DISSEMINATED NONSEMINOMATOUS TESTICULAR CANCER
    British Journal of Cancer
    
    R. Dewit et al., "TUMOR-MARKER CONCENTRATION AT THE START OF CHEMOTHERAPY IS A STRONGERPREDICTOR OF TREATMENT FAILURE THAN MARKER HALF-LIFE - A STUDY IN PATIENTS WITH DISSEMINATED NONSEMINOMATOUS TESTICULAR CANCER", British Journal of Cancer, 75(3), 1997, pp. 432-435
20. VERWEIJ J; DEMULDER PHM; DEGRAEFF A; VERMORKEN JB; WILDIERS J; KERGER J; SCHORNAGEL J; COGNETTI F; KIRKPATRICK A; SAHMOUD T; LEFEBVRE JL
    PHASE-II STUDY ON MITOXANTRONE IN ADENOID CYSTIC CARCINOMAS OF THE HEAD AND NECK
    Annals of oncology
    
    J. Verweij et al., "PHASE-II STUDY ON MITOXANTRONE IN ADENOID CYSTIC CARCINOMAS OF THE HEAD AND NECK", Annals of oncology, 7(8), 1996, pp. 867-869
21. VERHAGEN CAHHVM; VANHOESEL QGCM; SCHIJF CPT; DEMULDER PHM
    THE MANAGEMENT OF GRANULOSA-CELL TUMOR OF THE OVARY - A CASE-HISTORY
    Annals of oncology
    
    C.A.H.H.V.M. Verhagen et al., "THE MANAGEMENT OF GRANULOSA-CELL TUMOR OF THE OVARY - A CASE-HISTORY", Annals of oncology, 7(5), 1996, pp. 521-524
22. DEWIT R; SCHMITZ PIM; VERWEIJ J; DEBOERDENNERT M; DEMULDER PHM; PLANTING AST; VANDERBURG MEL; STOTER G
    ANALYSIS OF CUMULATIVE PROBABILITIES SHOWS THAT THE EFFICACY OF 5HT(3) ANTAGONIST PROPHYLAXIS IS NOT MAINTAINED
    Journal of clinical oncology
    
    R. Dewit et al., "ANALYSIS OF CUMULATIVE PROBABILITIES SHOWS THAT THE EFFICACY OF 5HT(3) ANTAGONIST PROPHYLAXIS IS NOT MAINTAINED", Journal of clinical oncology, 14(2), 1996, pp. 644-651
23. DEMULDER PHM; WEISSBACH L; JAKSE G; OSIEKA R; BLATTER J
    GEMCITABINE - A PHASE-II STUDY IN PATIENTS WITH ADVANCED RENAL-CANCER
    Cancer chemotherapy and pharmacology
    
    P.H.M. Demulder et al., "GEMCITABINE - A PHASE-II STUDY IN PATIENTS WITH ADVANCED RENAL-CANCER", Cancer chemotherapy and pharmacology, 37(5), 1996, pp. 491-495
24. ROHDE D; DEMULDER PHM; WEISSBACH L; OSIEKA R; BLATTER J; JAKSE G
    EXPERIMENTAL AND CLINICAL EFFICACY OF 2',2'-DIFLUORODEOXYCYTIDINE (GEMCITABINE) AGAINST RENAL-CELL CARCINOMA
    Oncology
    
    D. Rohde et al., "EXPERIMENTAL AND CLINICAL EFFICACY OF 2',2'-DIFLUORODEOXYCYTIDINE (GEMCITABINE) AGAINST RENAL-CELL CARCINOMA", Oncology, 53(6), 1996, pp. 476-481
25. VERWEIJ J; DEWIT R; DEMULDER PHM
    OPTIMAL-CONTROL OF ACUTE CISPLATIN-INDUCED EMESIS
    Oncology
    
    J. Verweij et al., "OPTIMAL-CONTROL OF ACUTE CISPLATIN-INDUCED EMESIS", Oncology, 53, 1996, pp. 56-64
26. KRUIT WHJ; PUNT CJA; GOEY SH; DEMULDER PHM; GRATAMA JW; EGGERMONT AMM; BOLHUIS RLH; STOTER G
    DOSE EFFICACY STUDY OF 2 SCHEDULES OF HIGH-DOSE BOLUS ADMINISTRATION OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN METASTATIC MELANOMA
    British Journal of Cancer
    
    W.H.J. Kruit et al., "DOSE EFFICACY STUDY OF 2 SCHEDULES OF HIGH-DOSE BOLUS ADMINISTRATION OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN METASTATIC MELANOMA", British Journal of Cancer, 74(6), 1996, pp. 951-955
27. VERWEIJ J; WANDERS J; GIL T; SCHOFFSKI P; CATIMEL G; TEVELDE A; DEMULDER PHM
    PHASE-II STUDY OF RHIZOXIN IN SQUAMOUS-CELL HEAD AND NECK-CANCER
    British Journal of Cancer
    
    J. Verweij et al., "PHASE-II STUDY OF RHIZOXIN IN SQUAMOUS-CELL HEAD AND NECK-CANCER", British Journal of Cancer, 73(3), 1996, pp. 400-402
28. STEERENBERG PA; BALEMANS LTM; KREMER BHA; KOPPENHAGEN FJ; DEMULDER PHM; DENOTTER W
    REDUCTION OF THERAPEUTIC EFFICACY BY A 2ND CYCLE OF PEG-IL-2
    Journal of immunotherapy with emphasis on tumor immunology
    
    P.A. Steerenberg et al., "REDUCTION OF THERAPEUTIC EFFICACY BY A 2ND CYCLE OF PEG-IL-2", Journal of immunotherapy with emphasis on tumor immunology, 18(1), 1995, pp. 45-51
29. BRAUSI M; JONES WG; FOSSA SD; DEMULDER PHM; DROZ JP; LENTZ MA; VANGLABBEKE M; PAWINSKI A
    HIGH-DOSE EPIRUBICIN IS EFFECTIVE IN MEASURABLE METASTATIC PROSTATE-CANCER - A PHASE-II STUDY OF THE EORTC GENITOURINARY GROUP
    European journal of cancer
    
    M. Brausi et al., "HIGH-DOSE EPIRUBICIN IS EFFECTIVE IN MEASURABLE METASTATIC PROSTATE-CANCER - A PHASE-II STUDY OF THE EORTC GENITOURINARY GROUP", European journal of cancer, 31A(10), 1995, pp. 1622-1626
30. PLANTING AST; VERMORKEN JB; CATIMEL G; DEMULDER PHM; DEGRAEFF A; OSTER W; VERDONK HER
    RANDOMIZED PHASE-II STUDY OF WEEKLY CISPLATIN WITH OR WITHOUT AMIFOSTINE IN PATIENTS WITH ADVANCED HEAD AND NECK-CANCER
    European journal of cancer
    
    A.S.T. Planting et al., "RANDOMIZED PHASE-II STUDY OF WEEKLY CISPLATIN WITH OR WITHOUT AMIFOSTINE IN PATIENTS WITH ADVANCED HEAD AND NECK-CANCER", European journal of cancer, 31A, 1995, pp. 392-392
31. PAWINSKI A; VANOOSTEROM AT; DEMULDER PHM; STOTER G; SVEDBERG A
    THE EFFICACY AND SAFETY OF LINOMIDE IN THE TREATMENT OF RENAL-CELL CARCINOMA [RCC] - AN EORTC PHASE-II STUDY
    European journal of cancer
    
    A. Pawinski et al., "THE EFFICACY AND SAFETY OF LINOMIDE IN THE TREATMENT OF RENAL-CELL CARCINOMA [RCC] - AN EORTC PHASE-II STUDY", European journal of cancer, 31A, 1995, pp. 461-461
32. DEMULDER PHM; DEWIT R
    EXPERIENCE WITH DOSE AND SCHEDULE VARIATIONS IN GERM-CELL TUMORS
    Anti-cancer drugs
    
    P.H.M. Demulder e R. Dewit, "EXPERIENCE WITH DOSE AND SCHEDULE VARIATIONS IN GERM-CELL TUMORS", Anti-cancer drugs, 6, 1995, pp. 43-52
33. VREUGDENHIL G; DEMULDER PHM; VANHOESEL Q
    SOFT-TISSUE SARCOMA AND HYPERCALCEMIA
    Annals of oncology
    
    G. Vreugdenhil et al., "SOFT-TISSUE SARCOMA AND HYPERCALCEMIA", Annals of oncology, 6(1), 1995, pp. 89-90
34. SCHORNAGEL JH; VERWEIJ J; DEMULDER PHM; COGNETTI F; VERMORKEN JB; CAPPELAERE P; ARMAND JP; WILDIERS J; DEGRAEFF A; CLAVEL M; SAHMOUD T; KIRKPATRICK A; LEFEBVRE JL
    RANDOMIZED PHASE-III TRIAL OF EDATREXATE VERSUS METHOTREXATE IN PATIENTS WITH METASTATIC AND OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER HEAD AND NECK-CANCER COOPERATIVE GROUP-STUDY/
    Journal of clinical oncology
    
    J.H. Schornagel et al., "RANDOMIZED PHASE-III TRIAL OF EDATREXATE VERSUS METHOTREXATE IN PATIENTS WITH METASTATIC AND OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER HEAD AND NECK-CANCER COOPERATIVE GROUP-STUDY/", Journal of clinical oncology, 13(7), 1995, pp. 1649-1655
35. DENOTTER W; HILL FWG; KLEIN WR; KOTEN JW; STEERENBERG PA; DEMULDER PHM; RHODE C; STEWART R; FABER JAJ; RUITENBERG EJ; RUTTEN VPMG
    THERAPY OF BOVINE OCULAR SQUAMOUS-CELL CARCINOMA WITH LOCAL DOSES OF INTERLEUKIN-2 - 67-PERCENT COMPLETE REGRESSIONS AFTER 20 MONTHS OF FOLLOW-UP
    Cancer immunology and immunotherapy
    
    W. Denotter et al., "THERAPY OF BOVINE OCULAR SQUAMOUS-CELL CARCINOMA WITH LOCAL DOSES OF INTERLEUKIN-2 - 67-PERCENT COMPLETE REGRESSIONS AFTER 20 MONTHS OF FOLLOW-UP", Cancer immunology and immunotherapy, 41(1), 1995, pp. 10-14
36. BALEMANS LTM; STEERENBERG PA; KREMER BHA; KOPPENHAGEN FJ; DEMULDER PHM; DENOTTER W
    SPECIFIC TUMOR MEMORY INDUCED BY POLYETHYLENE-GLYCOL-MODIFIED INTERLEUKIN-2 REQUIRES BOTH HELPER AND CYTOTOXIC T-CELLS
    Cancer immunology and immunotherapy
    
    L.T.M. Balemans et al., "SPECIFIC TUMOR MEMORY INDUCED BY POLYETHYLENE-GLYCOL-MODIFIED INTERLEUKIN-2 REQUIRES BOTH HELPER AND CYTOTOXIC T-CELLS", Cancer immunology and immunotherapy, 40(2), 1995, pp. 125-131
37. DRENTH JPH; DEKLEIJN EHMA; DEMULDER PHM; VANDERMEER JWM
    METASTATIC BREAST-CANCER PRESENTING AS FEVER, RASH, AND ARTHRITIS
    Cancer
    
    J.P.H. Drenth et al., "METASTATIC BREAST-CANCER PRESENTING AS FEVER, RASH, AND ARTHRITIS", Cancer, 75(7), 1995, pp. 1608-1611
38. DEWIT R; STOTER G; SLEIJFER DT; KAYE SB; DEMULDER PHM; HUININK WWT; SPAANDER PJ; DEPAUW M; SYLVESTER R
    4 CYCLES OF BEP VERSUS AN ALTERNATING REGIME OF PVB AND BEP IN PATIENTS WITH POOR-PROGNOSIS METASTATIC TESTICULAR NONSEMINOMA - A RANDOMIZED STUDY OF THE EORTC GENITOURINARY TRACT CANCER COOPERATIVE GROUP
    British Journal of Cancer
    
    R. Dewit et al., "4 CYCLES OF BEP VERSUS AN ALTERNATING REGIME OF PVB AND BEP IN PATIENTS WITH POOR-PROGNOSIS METASTATIC TESTICULAR NONSEMINOMA - A RANDOMIZED STUDY OF THE EORTC GENITOURINARY TRACT CANCER COOPERATIVE GROUP", British Journal of Cancer, 71(6), 1995, pp. 1311-1314
39. DEMULDER PHM; OOSTERHOF GON; BOUFFIOUX C; VANOOSTEROM AT; VERMEYLEN K; SYLVESTER R
    EORTC(30885) RANDOMIZED PHASE-III STUDY WITH RECOMBINANT INTERFERON-ALPHA AND RECOMBINANT INTERFERON-ALPHA AND INTERFERON-GAMMA IN PATIENTSWITH ADVANCED RENAL-CELL CARCINOMA
    British Journal of Cancer
    
    P.H.M. Demulder et al., "EORTC(30885) RANDOMIZED PHASE-III STUDY WITH RECOMBINANT INTERFERON-ALPHA AND RECOMBINANT INTERFERON-ALPHA AND INTERFERON-GAMMA IN PATIENTSWITH ADVANCED RENAL-CELL CARCINOMA", British Journal of Cancer, 71(2), 1995, pp. 371-375
40. BRUNTSCH U; HEINRICH B; KAYE SB; DEMULDER PHM; VANOOSTEROM A; PARIDAENS R; VERMORKEN JB; WANDERS J; FRANKLIN H; BAYSSAS M; VERWEIJ J
    DOCETAXEL (TAXOTERE) IN ADVANCED RENAL-CELL CANCER - A PHASE-II TRIALOF THE EORTC EARLY CLINICAL-TRIALS GROUP
    European journal of cancer
    
    U. Bruntsch et al., "DOCETAXEL (TAXOTERE) IN ADVANCED RENAL-CELL CANCER - A PHASE-II TRIALOF THE EORTC EARLY CLINICAL-TRIALS GROUP", European journal of cancer, 30A(8), 1994, pp. 1064-1067
41. CLAVEL M; VERMORKEN JB; COGNETTI F; CAPPELAERE P; DEMULDER PHM; SCHORNAGEL JH; TUENI EA; VERWEIJ J; WILDIERS J; CLERICO M; DALESIO O; KIRKPATRICK A; SNOW GB
    RANDOMIZED COMPARISON OF CISPLATIN, METHOTREXATE, BLEOMYCIN AND VINCRISTINE (CABO) VERSUS CISPLATIN AND 5-FLUOROURACIL (CF) VERSUS CISPLATIN (C) IN RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A PHASE-III STUDY OF THE EORTC HEAD AND NECK-CANCER COOPERATIVE GROUP
    Annals of oncology
    
    M. Clavel et al., "RANDOMIZED COMPARISON OF CISPLATIN, METHOTREXATE, BLEOMYCIN AND VINCRISTINE (CABO) VERSUS CISPLATIN AND 5-FLUOROURACIL (CF) VERSUS CISPLATIN (C) IN RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A PHASE-III STUDY OF THE EORTC HEAD AND NECK-CANCER COOPERATIVE GROUP", Annals of oncology, 5(6), 1994, pp. 521-526
42. WAGENER DJT; DEMULDER PHM; WILS JA
    MULTIMODALITY TREATMENT OF LOCALLY ADVANCED PANCREATIC-CANCER
    Annals of oncology
    
    D.J.T. Wagener et al., "MULTIMODALITY TREATMENT OF LOCALLY ADVANCED PANCREATIC-CANCER", Annals of oncology, 5, 1994, pp. 190000081-190000086
43. STOTER G; KAYE SB; DEMULDER PHM; LEVI R; RAGHAVAN D
    THE IMPORTANCE OF BLEOMYCIN IN COMBINATION CHEMOTHERAPY FOR GOOD-PROGNOSIS GERM-CELL CARCINOMA
    Journal of clinical oncology
    
    G. Stoter et al., "THE IMPORTANCE OF BLEOMYCIN IN COMBINATION CHEMOTHERAPY FOR GOOD-PROGNOSIS GERM-CELL CARCINOMA", Journal of clinical oncology, 12(3), 1994, pp. 644-645
44. DEMULDER PHM; CAPPELAERE P; COGNETTI F; VERWEIJ J; SCHORNAGEL JH; VERMORKEN JB; KIRKPATRICK A; LEFEBVRE JL
    A PHASE-II STUDY OF PIRARUBICIN IN PATIENTS WITH ADVANCED RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA
    Cancer chemotherapy and pharmacology
    
    P.H.M. Demulder et al., "A PHASE-II STUDY OF PIRARUBICIN IN PATIENTS WITH ADVANCED RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA", Cancer chemotherapy and pharmacology, 33(5), 1994, pp. 438-440
45. DEMULDER PHM; STERNBERG CN; VANOOSTEROM AT; FOSSA SD
    THE APPLICATION OF HEMATOPOIETIC GROWTH-FACTORS IN ADVANCED TRANSITIONAL-CELL CARCINOMA OF THE URINARY-TRACT
    Seminars in oncology
    
    P.H.M. Demulder et al., "THE APPLICATION OF HEMATOPOIETIC GROWTH-FACTORS IN ADVANCED TRANSITIONAL-CELL CARCINOMA OF THE URINARY-TRACT", Seminars in oncology, 21(1), 1994, pp. 65-69
46. BALEMANS LTM; STEERENBERG PA; KOPPENHAGEN FJ; KREMER BHA; DEMULDER PHM; CLAESSEN AME; SCHEPER RJ; DENOTTER W
    PEG-IL-2 THERAPY OF ADVANCED CANCER IN THE GUINEA-PIG - IMPACT OF THEPRIMARY TUMOR AND BENEFICIAL EFFECT OF CYCLOPHOSPHAMIDE
    International journal of cancer
    
    L.T.M. Balemans et al., "PEG-IL-2 THERAPY OF ADVANCED CANCER IN THE GUINEA-PIG - IMPACT OF THEPRIMARY TUMOR AND BENEFICIAL EFFECT OF CYCLOPHOSPHAMIDE", International journal of cancer, 58(6), 1994, pp. 871-876
47. VERMORKEN JB; VERWEIJ J; DEMULDER PHM; COGNETTI F; CLAVEL M; RODENHUIS S; KIRKPATRICK A; SNOW GB
    EPIRUBICIN IN PATIENTS WITH ADVANCED OR RECURRENT ADENOID CYSTIC CARCINOMA OF THE HEAD AND NECK - A PHASE-II STUDY OF THE EORTC HEAD AND NECK-CANCER COOPERATIVE GROUP
    Annals of oncology
    
    J.B. Vermorken et al., "EPIRUBICIN IN PATIENTS WITH ADVANCED OR RECURRENT ADENOID CYSTIC CARCINOMA OF THE HEAD AND NECK - A PHASE-II STUDY OF THE EORTC HEAD AND NECK-CANCER COOPERATIVE GROUP", Annals of oncology, 4(9), 1993, pp. 785-788
48. STERNBERG CN; DEMULDER PHM; VANOOSTEROM AT; FOSSA SD; GIANNARELLI D; SOEDIRMAN JR
    ESCALATED M-VAC CHEMOTHERAPY AND RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) IN PATIENTS WITH ADVANCED UROTHELIAL TRACT TUMORS
    Annals of oncology
    
    C.N. Sternberg et al., "ESCALATED M-VAC CHEMOTHERAPY AND RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) IN PATIENTS WITH ADVANCED UROTHELIAL TRACT TUMORS", Annals of oncology, 4(5), 1993, pp. 403-407
49. BALEMANS LTM; MATTIJSSEN V; STEERENBERG PA; VANDRIEL BEM; DEMULDER PHM; DENOTTER W
    LOCOREGIONAL THERAPY WITH POLYETHYLENE-GLYCOL-MODIFIED INTERLEUKIN-2 OF AN INTRADERMALLY GROWING HEPATOCELLULAR-CARCINOMA IN THE GUINEA-PIGINDUCES T-CELL-MEDIATED ANTITUMOR-ACTIVITY
    Cancer immunology and immunotherapy
    
    L.T.M. Balemans et al., "LOCOREGIONAL THERAPY WITH POLYETHYLENE-GLYCOL-MODIFIED INTERLEUKIN-2 OF AN INTRADERMALLY GROWING HEPATOCELLULAR-CARCINOMA IN THE GUINEA-PIGINDUCES T-CELL-MEDIATED ANTITUMOR-ACTIVITY", Cancer immunology and immunotherapy, 37(1), 1993, pp. 7-14
50. DENOTTER W; HILL FWG; KLEIN WR; KOTEN JW; STEERENBERG PA; DEMULDER PHM; RUTTEN VPMG; RUITENBERG EJ
    LOW-DOSES OF INTERLEUKIN-2 CAN CURE LARGE BOVINE OCULAR SQUAMOUS-CELLCARCINOMA
    Anticancer research
    
    W. Denotter et al., "LOW-DOSES OF INTERLEUKIN-2 CAN CURE LARGE BOVINE OCULAR SQUAMOUS-CELLCARCINOMA", Anticancer research, 13(6B), 1993, pp. 2453-2455
51. GRUTTERS JC; HERMUS ARMM; DEMULDER PHM; BEEX LVAM
    LONG-TERM FOLLOW-UP OF BREAST-CANCER PATIENTS TREATED FOR HYPERCALCEMIA WITH AMINOHYDROXYPROPYLIDENE BISPHOSPHONATE (APD)
    Breast cancer research and treatment
    
    J.C. Grutters et al., "LONG-TERM FOLLOW-UP OF BREAST-CANCER PATIENTS TREATED FOR HYPERCALCEMIA WITH AMINOHYDROXYPROPYLIDENE BISPHOSPHONATE (APD)", Breast cancer research and treatment, 25(3), 1993, pp. 277-281
52. MATTIJSSEN V; PETERS HM; SCHALKWIJK L; MANNI JJ; VANTHOFGROOTENBOER B; DEMULDER PHM; RUITER DJ
    E-CADHERIN EXPRESSION IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA IS ASSOCIATED WITH CLINICAL OUTCOME
    International journal of cancer
    
    V. Mattijssen et al., "E-CADHERIN EXPRESSION IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA IS ASSOCIATED WITH CLINICAL OUTCOME", International journal of cancer, 55(4), 1993, pp. 580-585
53. PUNT CJA; BURGHOUTS JTM; CROLES JJ; VANLIESSUM PA; DEMULDER PHM; KAMM Y
    CONTINUOUS-INFUSION OF HIGH-DOSE 5-FLUOROURACIL IN COMBINATION WITH LEUCOVORIN AND RECOMBINANT INTERFERON-ALPHA-2B IN PATIENTS WITH ADVANCED COLORECTAL-CANCER - A MULTICENTER PHASE-II STUDY
    Cancer
    
    C.J.A. Punt et al., "CONTINUOUS-INFUSION OF HIGH-DOSE 5-FLUOROURACIL IN COMBINATION WITH LEUCOVORIN AND RECOMBINANT INTERFERON-ALPHA-2B IN PATIENTS WITH ADVANCED COLORECTAL-CANCER - A MULTICENTER PHASE-II STUDY", Cancer, 72(7), 1993, pp. 2107-2111
54. TIBBEN JG; BOERMAN OC; CLAESSENS RAMJ; CORSTENS FHM; VANDEUREN M; DEMULDER PHM; VANDERMEER JWM; KEIJSER KGG; MASSUGER LFAG
    CYTOKINE RELEASE IN AN OVARIAN-CARCINOMA PATIENT FOLLOWING INTRAVENOUS ADMINISTRATION OF BISPECIFIC ANTIBODY OC TR F(AB')2/
    Journal of the National Cancer Institute
    
    J.G. Tibben et al., "CYTOKINE RELEASE IN AN OVARIAN-CARCINOMA PATIENT FOLLOWING INTRAVENOUS ADMINISTRATION OF BISPECIFIC ANTIBODY OC TR F(AB')2/", Journal of the National Cancer Institute, 85(12), 1993, pp. 1003-1004
55. SCHORNAGEL JH; VERWEIJ J; DEMULDER PHM; COGNETTI F; VERMORKEN JB; CAPPELAERE P; ARMAND JP; WILDIERS J; CLAVEL M; KIRKPATRICK A; LEFEBVRE JL
    A PHASE-II TRIAL OF 10-ETHYL-10-DEAZA-AMINOPTERIN, A NOVEL ANTIFOLATE, IN PATIENTS WITH ADVANCED AND OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    Annals of oncology
    
    J.H. Schornagel et al., "A PHASE-II TRIAL OF 10-ETHYL-10-DEAZA-AMINOPTERIN, A NOVEL ANTIFOLATE, IN PATIENTS WITH ADVANCED AND OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK", Annals of oncology, 3(3), 1992, pp. 223-226